Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2010
10/20/2010EP2240190A1 Nutraceutical composition and methods of use
10/20/2010EP2240022A2 Pharmaceutical compositions
10/20/2010EP2144897B1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/20/2010EP2114945B1 Pteridinone derivatives as pi3-kinases inhibitors
10/20/2010EP1951653B1 Salicylic acid derivatives
10/20/2010EP1626973B1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101868462A Method for the preparation of morphine compounds
10/20/2010CN101868453A Inhibitors of the interaction between MDM2 and P53
10/20/2010CN101868448A 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
10/20/2010CN101868231A Novel use of omega-3-fatty acid(s)
10/20/2010CN101865914A Method for detecting anti-inflammatory activity of musk
10/20/2010CN101863934A Salicylic acid glucosides methyl compound, and synthesis method and purposes thereof
10/20/2010CN101863878A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
10/20/2010CN101863877A Therapeutic agents useful for treating pain
10/20/2010CN101863867A Derivatives of flavonoids compounds and preparation method and application thereof
10/20/2010CN101862628A Biodegradable microencapsulated capsaicine and preparation method thereof
10/20/2010CN101862456A Remedy
10/20/2010CN101862453A New self emulsifying drug delivery system
10/20/2010CN101862441A Liniment containing natural Zingiber corallinum Hance essential oil with functions of analgesia, antiphlogosis, detumescence and itching-relieving
10/20/2010CN101862439A Anti-inflammatory throat lozenge containing natural Zingiber corallinum Hance essential oil
10/20/2010CN101862421A Chinese medicinal ointment composition
10/20/2010CN101862404A Plaster for activating meridians and collaterals-
10/20/2010CN101862401A Chinese medicinal boiled packing bag and method for manufacturing same
10/20/2010CN101862396A Chinese medicament for treating rheumatism
10/20/2010CN101862377A Chinese medicinal composition for treating traumatic injury of livestock and poultry and preparation method thereof
10/20/2010CN101862342A External medicament for treating dermatophytosis
10/20/2010CN101862331A New use of methyl liensinine
10/20/2010CN101862318A Combined medicament-combined linolenic acid capable of preventing and fundamentally treating thromboembolic diseases
10/20/2010CN101862317A Pregabalin derivatives for the treatment of fibromyalgia and other disorders
10/20/2010CN101862312A New application of 6-gingerol
10/20/2010CN101862311A Penetration promoting and eyesight improving eye drop
10/20/2010CN101862297A Water-insoluble medicine sustained-release pellet, sustained-release orally disintegrating tablet thereof and preparation method thereof
10/20/2010CN101862292A Ibuprofen suspension
10/20/2010CN101862283A Anti-inflammatory and analgesic lipstick containing natural Zingiber corallinum Hance essential oil
10/20/2010CN101862233A Drug-delivery endovascular stent and method for treating restenosis
10/20/2010CN101518655B Application of human interleukin-24 gene recombined vector mediated by adenovirus in preparing tumor analgesic medicament
10/20/2010CN101367862B Method for quickly and massively separating high purity triptolide from thunder god vine
10/20/2010CN101297948B Chinese medicine lotion preparation for treating chest wall soft tissue injury
10/20/2010CN101259257B Preparation of Chinese medicine for treating facial neuritis
10/20/2010CN101152242B Medicament for treating Chinese medical stubborn paralysis
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816358 Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816317 Tripeptide prodrug compounds
10/19/2010US7815933 Pre-concentrate emulsion of a nitrogen oxide-releasing NSAID, a surfactant, and an oil or fat, for oral administration; forming an oil-in-water emulsion with gastrointestinal fluids; side- effect reduction; bioavailability; treating pain and inflammation
10/19/2010CA2518745C S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2458853C Use of fucans in the treatment of adhesions, arthritis and psoriasis
10/19/2010CA2458699C Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
10/19/2010CA2451422C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
10/19/2010CA2448089C Thiolalkyl benzoic acid derivatives
10/19/2010CA2439791C Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/19/2010CA2433417C Novel 1,2-diphenylethene derivatives for treatment of immune diseases
10/19/2010CA2427282C Mixtures or organic compounds for the treatment of airway diseases
10/19/2010CA2415577C Use of cox-2 inhibitors for preventing immunodeficiency
10/19/2010CA2399840C Use of roflumilast or pumafentrine in combination with methotrexate for the treatment of arthritic diseases
10/19/2010CA2399434C Isolation and transplantation of retinal stem cells
10/19/2010CA2376031C Product from starfish
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2325803C Novel omega conotoxin peptides
10/14/2010WO2010117050A1 Solid preparation containing dibenz[b,e]oxepine derivative
10/14/2010WO2010116282A1 4, 5-dihydro-lh-pyrazole compounds and their pharmaceutical uses
10/14/2010WO2010116084A1 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010115252A1 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-α MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/14/2010WO2010077680A3 Compositions of protein receptor tyrosine kinase inhibitors
10/14/2010US20100261784 Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
10/14/2010US20100261780 Highly Acidic Chitosan-Nucleic Acid Polyplex Compositions
10/14/2010US20100261766 Phenyl-Oxetanyl-Derivatives
10/14/2010US20100261762 Serotonin and norepinephrine reuptake inhibitor
10/14/2010US20100261753 Methods for preventing and/or treating degenerative disorders of the central nervous system
10/14/2010US20100261732 1, 2, 4 -triazole derivatives as serotonergic modulators
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261725 Compounds that modulate intracellular calcium
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261701 8-Substituted isoquinoline derivative and the use thereof
10/14/2010US20100261672 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/14/2010US20100261663 Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof
10/14/2010US20100261662 Utilization of mural thrombus for local drug delivery into vascular tissue
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260867 Methods and compositions for the prevention and treatment of inflammatory diseases
10/14/2010US20100260854 Granulate for the formulation of orodispersible tablets
10/14/2010US20100260848 System for controlled release of an active principle and method for preparation
10/14/2010US20100260823 Preparation with marine collagen for protease inhibition
10/14/2010US20100260768 Anti mif antibodies
10/14/2010US20100260767 Composition and Method for Treating Inflammatory Disorders
10/14/2010US20100260749 Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260707 Antigen associated with rheumatoid arthritis
1 ... 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 ... 1272